Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
22%
ALSO IN THNR
THNR
19
HOLDINGS
26%
ALSO IN PPH
SECTOR DRIFT (PPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 19.1% | 12.5% | 12.5% |
|
MERCK & CO. INC. | 9.6% | 5.9% | 5.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.6% | 11.4% | 5.6% |
|
PFIZER INC | 4.7% | 5.1% | 4.7% |
|
ABBVIE INC | 4.0% | 4.8% | 4.0% |
PPH Overweight Relative to THNR
 |
NOVARTIS AG-ADR | 10.6% |
|
ELI LILLY & CO | 6.6% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 5.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.9% |
|
MCKESSON CORP | 4.7% |
|
JOHNSON & JOHNSON | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
CENCORA INC | 3.9% |
|
MERCK & CO. INC. | 3.7% |
|
ZOETIS INC | 3.3% |
PPH Underweight Relative to THNR
|
AMGEN INC | -7.7% |
|
REGENERON PHARMACEUTICALS | -6.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -6.5% |
|
SHIONOGI & CO LTD | -5.9% |
|
NOVO-NORDISK A/S-SPONS ADR | -5.7% |
|
ROCHE HOLDING LTD | -5.5% |
|
ASTRAZENECA PLC | -5.0% |
 |
INNOVENT BIOLOGICS, INC. | -4.4% |
 |
CHINA PHARMACEUTICAL GROUP | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.8% |